Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Gastrointestinal Bleeding

Mayo Clinic. Authors: Vivek N. Iyer, MD, MPH; Dinesh R. Apala, MBBS; Bibek S. Pannu, MBBS; Aditya Kotecha, MBBS; Waleed Brinjikji, MD; Michael D. Leise, MD;
Patrick S. Kamath, MD; Sanjay Misra, MD; Kebede H. Begna, MD;
Rodrigo Cartin-Ceba, MD; Hilary M. DuBrock, MD; Michael J. Krowka, MD;
Erin K. O’Brien, MD; Rajiv K. Pruthi, MBBS; Darrell R. Schroeder, MS;
and Karen L. Swanson, MD.

This article can be purchased directly from the publisher. Click to view the article description and purchase options.

Scientific Literature – February, 2018

Provider topics: Anemia/ Iron Deficiency, Gastrointestinal, Nosebleeds or Epistaxis

Patient topics: Anemia/ Iron Deficiency, Gastrointestinal, Nosebleeds